Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018

Antimicrobials and antibiotics form a major share of the animal health market. Animal antimicrobials gained a greater importance in the animal health industry in the past 20 years, mainly due to growing need to preserve the health and welfare of animals. Most of the antimicrobial agents were also used as growth promoters as well. With this, the animal antimicrobials market witnessed a bullish growth from 1990’s to 2006.

However, gradually, there were growing concerns about emergence of antibiotic-resistant bacteria which led to worldwide initiatives to minimize the use of antimicrobial agents as a growth promoter in food-producing animals. In Europe, in 2006, a complete ban was imposed on use of antimicrobial agents in food-producing animals, which brought a huge setback to the growing market for antimicrobial and antibiotics in Europe.

At present, the global antimicrobials and antibiotics market is driven by the growing need to preserve animal health owing to rising demand for animal proteins across the globe, and growing demand in the companion animals segment. Growing livestock population, increasing incidences of disease outbreaks and increase in the companion animal ownership are some of the factors driving the growth of this market to a certain extent. Besides the structural market drivers, there are strong geographic drivers for the growth of the animal antimicrobials and antibiotics market. The emerging markets are becoming increasingly attractive. The Asian and Latin American region form one of the most promising animal antimicrobials and antibiotics markets in the world. Developing countries such as China and India have a relatively high CAGR rate and are expected to witness significant market growth in the forecast period. The growth in these regions is mainly attributed to the rise in demand for animal protein products, along with an increase in the trend of companion animal ownership in these regions.

Today, the animal antimicrobials and antibiotics market showcase a sluggish growth, owing to the regulatory authorities restricting their use, increased usage of in-feed enzymes, competitive exclusion products and probiotics as an alternative to antibiotics and prophylactic use of antibiotics being replaced by good husbandry, environment and hygienic practices.
Tetracyclines dominated the animal antimicrobials and antibiotics product segment in 2013, accounting for around 60% of the market revenue. This was followed by others segment, which accounted for 16% of the global animal antimicrobials and antibiotics product market in 2013. In the global antimicrobials and antibiotics animal market, pigs dominated the market with a share of close to 25%. In the mode of delivery segment of animal antimicrobials and antibiotics market, premix was the major revenue contributor in 2013, with an estimated share of nearly 49%.

North America dominated the animal antimicrobials and antibiotics market in 2013. However, the market share of this region will decrease to 27%, primarily due to the regulatory ban on the use of antibiotics announced in the U.S. At the same time, Asia and Latin America are poised to grow at a CAGR of 6% to 8% in the forecast period; this growth is largely driven by the increased urbanization, rising disposable incomes, increase in the demand for animal products and the increasing trend of pet ownerships in these regions.

The global animal antimicrobials and antibiotics market is consolidated with Zoetis Inc. (U.S.), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Merial (U.S.), Bayer Animal Health (Germany) holding around 75% of the total market. Other major players in this market are Virbac Animal Health (U.S.), and CEVA Sante Animale (U.S.).

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on the product portfolios offered by the top players in the animal antimicrobials and antibiotics market. The report analyzes the animal antimicrobials and antibiotics market by animals type, mode of delivery type and by product type across all geographies.

‧ Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the animal antimicrobials and antibiotics market.

‧ Market Development: Comprehensive information about the lucrative emerging markets by product, functionality, and geography.

‧ Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the animal antimicrobials and antibiotics market.

‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the animal antimicrobials and antibiotics market.

Table of Contents

1 Introduction (Page No. - 22)
1.1 Objectives Of The Study
1.2 Report Description
1. 3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size Estimation
1.5.2 Market Crackdown And Data Triangulation
1.5.3 Market Share Estimation
1.5.4 Key Data From Secondary Sources
1.5.5 Key Data Points From Primary Sources
1.5.6 Assumptions

2 Executive Summary (Page No. - 38)

3 Premium Insights (Page No. - 43)
3.1 Growing Consumption Of Animal Protein Products Provides Significant Growth Opportunities For Antimicrobials Market
3.2 Growing Per Capita Companion Animal Heatlh Expenditure To Drive The Market Growth
3.3 Regulatory Ban On Unauthorized Usage Of Antibiotics Curbing The Growth
3.4 High-Growth Potential Of Emerging Markets In Asia-Pacific, Middle East, And Latin America

4 Market Overview (Page No. - 49)
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Key Market Drivers
4.3.1.1 Rising Demands For Livestock Products Due To Growing Livestock Population Worldwide
4.3.1.2 Increasing Incidences Of Animal Disease Outbreaks Leading To High Utilization Of Antibiotics
4.3.1.3 Increased Use Of Approved Antimicrobial Agents To Promote Growth And Feed Efficiency In Food Animals
4.3.1.4 Growing Demand For Animal Antimicrobials In China
4.3.1.5 Increase In The Companion Animal Ownership Across The World
4.3.2 Key Market Restraints
4.3.2.1 Regulatory Authorities Curbing The Growth Of Antimicrobials And Antibiotics Market
4.3.2.2 Dearth Of New Antibiotics In The Market
4.3.2.3 Routine Prophylactic Use Of Antibiotics Being Replaced By Good Husbandry, And Hygiene Practices
4.3.2.4 Increased Use Of In-Feed Enzymes, Competitive Exclusion Products Or Probiotics As An Alternatives To Antibiotics
4.3.3 Key Market Opportunities
4.3.3.1 Growing Demand For Pet Animals In The Emerging Markets
4.3.3.2 Rapid Growth In Pet Health Insurance Is Driving The Animal Antimicrobials And Antibiotics Market
4.4 Global Market Share Analysis

5 Veterinary Antimicrobials And Antibiotics Market, By Product (Page No. - 66)
5.1 Introduction
5.1.1 Tetracyclines
5.1.2 Penicillins
5.1.3 Sulfonamides
5.1.4 Macrolides
5.1.5 Aminoglycosides
5.1.6 Cephalosporins
5.1.7 Others

6 Veterinary Antimicrobials And Antibiotics Market, By Mode Of Delivery (Page No. - 83)
6.1. Introduction
6.1.1 Premixes
6.1.2 Oral Powders & Solutions
6.1.3 Injections
6.1.4 Intramammary Preparations
6.1.5 Other Preparations

7 Veterinary Antimicrobials And Antibiotics Market, By Type Of Animal (Page No. - 98)
7.1 Introduction
7.2 Food-Producing Animals
7.2.1 Cattle
7.2.2 Pigs
7.2.3 Poultry
7.2.4 Sheep And Goats
7.3 Companion Animals
7.3.1 Dogs
7.3.2 Cats
7.3.3 Horses
7.4 Other Animals

8 Geographic Analysis (Page No. - 124)
8.1 Introduction
8.1.1 North America
8.1.1.1 U.S.
8.1.1.2 Canada
8.1.2 Europe
8.1.2.1 U.K.
8.1.2.2 Germany
8.1.2.3 France
8.1.2.4 Italy
8.1.2.5 Spain
8.1.2.6 Rest Of Europe
8.1.3 Asia-Pacific
8.1.3.1 Japan
8.1.3.2 China
8.1.3.3 India
8.1.3.4 Rest Of Asia-Pacific
8.1.4 Rest Of The World (Row)
8.1.4.1 Latin America
8.1.4.2 Middle East And Africa

9 Competitive Landscape (Page No. - 213)
9.1 Introduction
9.2 Mergers And Acquisitions
9.3 New Product Launches
9.4 Agreements, Collaborations, And Partnerships
9.5 Expansions
9.6 Others

10 Company Profiles (Business Overview, Products, Financials, Growth Strategy, Recent Developments, Swot Analysis, & Mnm View)* (Page No. - 227)
10.1 Zoetis, Inc.
10.2 Merck And Co., Inc.
10.3 Bayer Ag
10.4 Virbac Sa
10.5 Eli Lilly And Company
10.6 Boehringer Ingelheim
10.7 Sanofi
10.8 Novartis Ag
10.9 Ceva Sante Animale
10.10 Vetoquinol

*Details On Business Overview, Products, Financials, Growth Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.